05530101 is referenced by 1356 patents and cites 13 patents.

Novel methods for producing, and compositions of, humanized immunoglobulins having one or more complementarity determining regions (CDR's) and possible additional amino acids from a donor immunoglobulin and a framework region from an accepting human immunoglobulin are provided. Each humanized immunoglobulin chain will usually comprise, in addition to the CDR's, amino acids from the donor immunoglobulin framework that are, e.g., capable of interacting with the CDR's to effect binding affinity, such as one or more amino acids which are immediately adjacent to a CDR in the donor immunoglobulin or those within about 3 .ANG. as predicted by molecular modeling. The heavy and light chains may each be designed by using any one or all of various position criteria. When combined into an intact antibody, the humanized immunoglobulins of the present invention will be substantially non-immunogenic in humans and retain substantially the same affinity as the donor immunoglobulin to the antigen, such as a protein or other compound containing an epitope.

Title
Humanized immunoglobulins
Application Number
290975
Publication Number
5530101
Application Date
December 19, 1990
Publication Date
June 25, 1996
Inventor
Harold E Selick
Belmont
CA, US
Cary L Queen
Los Altos
CA, US
Agent
Townsend and Townsend and Crew
Assignee
Protein Design Labs
CA, US
IPC
C07K 16/28
A61K 39/395
View Original Source